Hester Biosciences informs about statement of investor complaints

05 Oct 2017 Evaluate

Hester Biosciences has informed about Statement Grievance Redressal Mechanism under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the quarter ended on 30 September 2017.

The above information is a part of company’s filings submitted to BSE.

 

Hester Biosciences Share Price

1583.30 8.35 (0.53%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×